These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24013441)

  • 1. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China.
    Li RC; Huang T; Li Y; Luo D; Tao J; Fu B; Si G; Nong Y; Mo Z; Liao X; Luan I; Tang H; Rathi N; Karkada N; Han HH
    Hum Vaccin Immunother; 2014; 10(1):11-8. PubMed ID: 24013441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: randomized, double-blind, placebo-controlled Phase I studies.
    Li RC; Li YP; Mo ZJ; Luo D; Huang T; Kong JL; Wang LH; Song NS; Liu A; Zhang H; Liao X; Karkada N; Han HH
    Hum Vaccin Immunother; 2013 Aug; 9(8):1638-42. PubMed ID: 23807360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.
    Cunliffe NA; Witte D; Ngwira BM; Todd S; Bostock NJ; Turner AM; Chimpeni P; Victor JC; Steele AD; Bouckenooghe A; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1(0 1):A36-43. PubMed ID: 22520135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, Immunogenicity and Safety of a Human Rotavirus Vaccine RIX4414 in Singaporean Infants.
    Phua KB; Lim FS; Quak SH; Lee BW; Teoh YL; Suryakiran PV; Han HH; Bock HL
    Ann Acad Med Singap; 2016 Feb; 45(2):44-50. PubMed ID: 27125345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
    Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
    Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: a randomized, controlled trial.
    Lau YL; Nelson EA; Poon KH; Chan PK; Chiu S; Sung R; Leung CW; Ng D; Ma YM; Chan D; Lee TL; Tang J; Kwan YW; Ip P; Ho M; Fung LW; Tang H; Suryakiran PV; Han HH; Bock H;
    Vaccine; 2013 Apr; 31(18):2253-9. PubMed ID: 23499605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
    Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.
    Iwata S; Nakata S; Ukae S; Koizumi Y; Morita Y; Kuroki H; Tanaka Y; Shizuya T; Schödel F; Brown ML; Lawrence J
    Hum Vaccin Immunother; 2013 Aug; 9(8):1626-33. PubMed ID: 23732903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants.
    Li RC; Huang T; Li Y; Wang LH; Tao J; Fu B; Si G; Nong Y; Mo Z; Liao X; Luan I; Tang H; Rathi N; Karkada N; Han HH
    Hum Vaccin Immunother; 2016 Mar; 12(3):785-93. PubMed ID: 27149266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
    Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants.
    Wu Z; Li Q; Liu Y; Lv H; Mo Z; Li F; Yu Q; Jin F; Chen W; Zhang Y; Huang T; Hu X; Xia W; Gao J; Zhou H; Bai X; Liu Y; Liang Z; Jiang Z; Chen Y; Zhang J; Du J; Yang B; Xing B; Xing Y; Dong B; Yang Q; Shi C; Yan T; Ruan B; Shi H; Fan X; Feng D; Lv W; Zhang D; Kong X; Zhou L; Que D; Chen H; Chen Z; Guo X; Zhou W; Wu C; Zhou Q; Liu Y; Qiao J; Wang Y; Li X; Duan K; Zhao Y; Xu G; Yang X
    Virol Sin; 2022 Oct; 37(5):724-730. PubMed ID: 35926726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.
    Vesikari T; Karvonen A; Puustinen L; Zeng SQ; Szakal ED; Delem A; De Vos B
    Pediatr Infect Dis J; 2004 Oct; 23(10):937-43. PubMed ID: 15602194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.
    Salinas B; Pérez Schael I; Linhares AC; Ruiz Palacios GM; Guerrero ML; Yarzábal JP; Cervantes Y; Costa Clemens S; Damaso S; Hardt K; De Vos B
    Pediatr Infect Dis J; 2005 Sep; 24(9):807-16. PubMed ID: 16148848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.
    Steele AD; Neuzil KM; Cunliffe NA; Madhi SA; Bos P; Ngwira B; Witte D; Todd S; Louw C; Kirsten M; Aspinall S; Van Doorn LJ; Bouckenooghe A; Suryakiran PV; Han HH
    BMC Infect Dis; 2012 Sep; 12():213. PubMed ID: 22974466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis.
    McCormack PL; Keam SJ
    Paediatr Drugs; 2009; 11(1):75-88. PubMed ID: 19127963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial.
    Mo Z; Mo Y; Li M; Tao J; Yang X; Kong J; Wei D; Fu B; Liao X; Chu J; Qiu Y; Hille DA; Nelson M; Kaplan SS
    Vaccine; 2017 Oct; 35(43):5897-5904. PubMed ID: 28935470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.